Background and Purpose-A matricellular protein tenascin-C is implicated in early brain injury after experimental subarachnoid hemorrhage (SAH). This study first evaluated the role of another matricellular protein periostin and the relationships with tenascin-C in post-SAH early brain injury. Methods-Wild-type (n=226) and tenascin-C knockout (n=9) C57BL/6 male adult mice underwent sham or filament perforation SAH modeling. Vehicle, anti-periostin antibody, or recombinant periostin was randomly administrated by an intracerebroventricular injection at 30 minutes post-modeling. Neuroscores, SAH grading, brain water content, immunostaining, and Western blotting were blindly evaluated at 24 to 48 hours post-SAH. Results-Periostin was induced in brain capillary endothelial cells and neurons at 24 hours post-SAH. Anti-periostin antibody improved post-SAH neurobehavior, brain edema, and blood-brain barrier disruption associated with downregulation of tenascin-C, inactivation of p38, extracellular signal-related kinase 1/2 and matrix metalloproteinase-9, and subsequent preservation of zona occludens-1. Recombinant periostin aggravated post-SAH brain edema and tenascin-C induction. Tenascin-C knockout prevented post-SAH neurobehavioral impairments and periostin induction. 
A ccumulating evidences suggest that early brain injury (EBI) is the primary cause of poor outcome after aneurysmal subarachnoid hemorrhage (SAH). 1 One of the most important pathological manifestations of EBI is the bloodbrain barrier (BBB) disruption, and therefore, elucidation of the pathogenesis is crucial to develop new therapies against EBI and to improve outcomes after SAH. 2 Periostin is a matricellular protein and activates many signaling pathways, including mitogen-activated protein kinase (MAPK) through integrins. 3 Periostin also directly interacts with another matricellular protein tenascin-C (TNC), 3 which was reported to cause post-SAH EBI via MAPK activation. 4, 5 However, the role of periostin has never been studied in the context of SAH. The aim of this study was to evaluate the role of periostin and the relationships with TNC in post-SAH EBI by focusing on BBB disruption.
Methods
Expanded Methods is available in the online-only Data Supplement.
The institutional animal care committee approved all protocols. SAH endovascular perforation models were produced, and sham-operated models underwent identical procedures except that the suture was withdrawn without puncture in wild-type (WT) and TNC-knockout (TNKO) C57BL/6 male adult mice. 5 First, 143 WT mice were randomly divided into sham+vehicle (n=25), sham+1 μg anti-periostin antibody (n=24), SAH+vehicle (n=39), SAH+0.04 μg anti-periostin antibody (n=9), SAH+0.2 μg anti-periostin antibody (n=8), and SAH+1 μg anti-periostin antibody (n=38) groups. The vehicle (2 μL phosphate-buffered saline) or anti-periostin antibody (R&D System) was intracerebroventricularly administrated 30 minutes post-surgery, and 18-point neuroscores, 18-point SAH grading, and brain water content were blindly evaluated at 24 and 48 hours. 5 Immunoglobulin G (IgG; Vector Laboratories) and periostin immunostainings (Abcam) on the left temporal cortex at 1.0 mm posterior to the bregma and Western blotting on the left cerebral cortex (perforation side) using anti-periostin (Abcam), antiphosphorylated p38, antiphosphorylated ERK (extracellular signal-related kinase) 1/2 (Cell Signaling), antiphosphorylated JNK (c-Jun N-terminal kinase; Santa Cruz Biotechnology), anti-MMP (matrix metalloproteinase)-9 (EMD Millipore), anti-zona occludens-1 (Thermo Fisher Scientific), anti-TNC (IBL-Japan), and anti-β-tubulin (Santa Cruz Biotechnology) antibodies were assessed at 24 hours post-surgery as previously described. 2, 5 Second, to exclude the possibility of a nonspecific response to intracerebroventricular protein injection, 1 μg normal IgG (Abcam) was administrated to SAH WT mice (n=3), and the effects on neuroscores, SAH grading, and brain water content were evaluated at 24 hours.
Third, 70 WT mice were randomly divided into sham+vehicle (n=12), sham+1 μg recombinant periostin (r-periostin; n=12), SAH+vehicle (n=17), SAH+0.2 μg r-periostin (n=9), and SAH+1 μg r-periostin (n=20) groups. The vehicle (2 μL phosphate-buffered saline) or r-periostin (R&D system) was intracerebroventricularly administrated 30 minutes post-surgery. Neuroscores, SAH grading, brain water content, and Western blotting for TNC were blindly evaluated at 24 hours post-surgery as described earlier.
Fourth, 19 mice were randomly divided into sham+WT (n=4), sham+TNKO (n=4), SAH+WT (n=6), and SAH+TNKO (n=5) groups. After 24 hours, neuroscores, SAH grading, and Western blotting for TNC and periostin were blindly evaluated.
Data were expressed as median±25th-75th percentiles or mean±SD and were analyzed using Mann-Whitney U test, Kruskal-Wallis test followed by Steel-Dwass multiple comparisons, one-way analysis of variance with Tukey-Kramer post hoc tests, or χ 2 tests as appropriate. P<0.05 was considered significant.
Results

Periostin Neutralization Ameliorates EBI
Physiological parameters were similar among the groups (data not shown). No sham-operated mice died. The mortality was not significantly different among the vehicle (30.8%), 0.04 μg (33.3%), 0.2 μg (25.0%), and 1 μg (26.3%) anti-periostin antibody-treated SAH groups. SAH grade was similar among the groups at both 24 and 48 hours (Figures I and II in the onlineonly Data Supplement). Anti-periostin antibody dose-dependently prevented post-SAH neurobehavioral impairments and brain edema, and 1 μg anti-periostin antibody showed neuroprotective effects even at 48 hours (Figure 1 ; Figure II in the online-only Data Supplement).
One-microgram anti-periostin antibody had no effects on sham mice, but significantly suppressed post-SAH periostin induction in brain capillary endothelial cells and neurons, as well as IgG extravasation, associated with inhibition of 
R-Periostin Aggravates EBI
R-periostin had no significant effects on physiological parameters, mortality, neuroscores, and SAH grading in sham or SAH animals, but 1 μg r-periostin significantly aggravated post-SAH brain edema and TNC induction in brain (Figure 2 ; Figure VII in the online-only Data Supplement).
TNKO Prevents Post-SAH Periostin Induction
Physiological parameters, mortality, and SAH grading were not significantly affected by TNKO in both sham and SAH animals ( Figure VIII in the online-only Data Supplement). TNKO had no effects on neuroscores and brain periostin levels in sham mice. However, TNKO significantly suppressed post-SAH neurobehavioral impairments and periostin induction ( Figure 3) .
Discussion
This study first demonstrated that periostin was upregulated in cerebral cortex after experimental SAH and was responsible for EBI, which was mediated possibly by p38/ERK/MMP-9 signaling pathways. Anti-periostin antibody suppressed periostin expression in brain capillary endothelial cells and EBI as evaluated by neuroscore, brain edema, and BBB permeability. Meanwhile, we found the interaction of periostin with TNC, which is another mediator of BBB disruption after SAH. 2, 5 A matricellular protein periostin is present at low levels in most adult tissues and highly expressed at sites of injury or inflammation. 3 Current evidence demonstrates that periostin activates intracellular signaling pathways, including MAPK through integrins, and modulates multiple downstream proteins, such as MMP-9, contributing to tissue injury. 3 The mechanisms of EBI development are indistinct, but previous studies verified that MAPKs were pivotal for post-SAH EBI. 6 Activated MAPKs induced and activated downstream MMP-9 to degrade cerebral microvessel basal lamina and tight junction protein zona occludens-1, causing BBB disruption and brain edema formation. 5, 6 This study was the first to show the link between periostin and post-SAH BBB disruption via MAPKs and MMP-9.
Periostin also directly interacts with another matricellular protein TNC through its fasciclin I domains. 3 TNC is downregulated in healthy tissues and transiently induced during inflammatory responses. 7 Our previous studies showed that TNC was induced to cause post-SAH EBI in terms of neuronal apoptosis and BBB disruption by activating MAPKs and MMP-9. 4, 5 In this study, periostin neutralization suppressed Periostin splicing variants may show different functions depending on a disease. Periostin splicing variant lacking exon 17, but not full-length periostin, revealed neuroprotective effects in transient focal cerebral ischemia in mice. 8 In contrast, neutralization of full-length periostin reduced myocardial infarction in rats. 9 In this study, neutralizing full-length periostin prevented post-SAH EBI. The role of periostin splicing variants remains unexamined in SAH, and further studies are needed.
In this study, r-periostin was found to worsen post-SAH cerebral edema but not neuroscores, possibly by limited sensitivities of the neuroscore system to evaluate worse scores than median scores of 6 in the SAH+vehicle animals because animals with the minimum score 2 never survive. Other limitations include no studies of more translational intravenous application and long-term effects of anti-periostin antibody, needing further studies.
Conclusions
Periostin neutralization prevented post-SAH BBB disruption associated with inactivation of p38/ERK/MMP-9 and downregulation of TNC. Targeted suppression of periostin in post-SAH brain may be promising. 
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